Food and Drug Administration Commissioner Scott Gottlieb, testifying before a House subcommittee in May. There are "very tight restrictions" being placed on the distribution and use of Dsuvia, Gottlieb said Friday in addressing the FDA's approval of the new opioid. But critics of the FDA decision say the drug is unnecessary. (Chip Somodevilla/Getty Images)
